Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
https://dxm-atlas.org/en/interactions/harmalas/
CompareKey points for this combination
The concern with DXM and harmalas rests on MAO-A inhibition by their components [9]. DMT without MAOIs has its own entry.
General concepts in this text
MAO-A
A form of the MAO enzyme involved in breaking down some chemical messengers, including serotonin.
These messengers are monoamines. MAO-A and MAO-B are two different forms of monoamine oxidase.
Sources: MAO-A
- MedlinePlus Genetics: MAOA gene — Normal Function · Page last updated 2017-05-01; accessed 2026-10-13
- Edmondson, Binda, Mattevi: Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B · Arch Biochem Biophys. 2007;464(2):269–276; DOI 10.1016/j.abb.2007.05.006; PMID 17573034
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
How can the effects add up?
ⓘ
MAO — monoamine oxidase
An enzyme involved in breaking down serotonin.
Breakdown and reuptake are different processes.
Sources: MAO — monoamine oxidase
- OpenStax: Neurotransmitters Made from Amino Acids · Introduction to Behavioral Neuroscience, published 2024-11-13
Serotonin toxicity
A condition caused by excessive serotonin activity in the nervous system.
Also called serotonin syndrome. Features can include tremor and involuntary muscle jerks, raised body temperature, a fast heartbeat, agitation or confusion.
Sources: Serotonin toxicity
- Ables and Nagubilli: Prevention, Diagnosis, and Management of Serotonin Syndrome · American Family Physician 81(9), 1139–1142 (2010)
- Chiew and Isbister: Management of serotonin syndrome (toxicity) · British Journal of Clinical Pharmacology 91(3), 654–661 (2025); first published 26 June 2024; DOI 10.1111/bcp.16152
Sources
Check the review’s wording
The concern rests on MAO-A inhibition by harmala components. The directory has a dedicated entry for DMT without MAOIs [9].
- [9] Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions · Open publication